Cornerstone Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.57M Buy
18,006
+708
+4% +$165K 0.38% 50
2026
Q1
$4.23M Buy
17,298
+117
+0.7% +$27.3K 0.4% 48
2025
Q4
$3.56M Sell
17,181
-854
-5% -$169K 0.34% 55
2025
Q3
$3.34M Buy
18,035
+727
+4% +$125K 0.33% 55
2025
Q2
$2.64M Buy
17,308
+28
+0.2% +$4.3K 0.28% 59
2025
Q1
$2.67M Buy
17,280
+309
+2% +$48.3K 0.31% 54
2024
Q4
$2.65M Sell
16,971
-35
-0.2% -$5.42K 0.3% 55
2024
Q3
$2.76M Sell
17,006
-123
-0.7% -$19.6K 0.36% 54
2024
Q2
$2.5M Sell
17,129
-761
-4% -$113K 0.35% 54
2024
Q1
$2.83M Sell
17,890
-717
-4% -$114K 0.4% 52
2023
Q4
$2.92M Sell
18,607
-62
-0.3% -$9.51K 0.45% 47
2023
Q3
$2.91M Sell
18,669
-924
-5% -$152K 0.51% 41
2023
Q2
$3.24M Sell
19,593
-778
-4% -$126K 0.57% 37
2023
Q1
$3.16M Buy
20,371
+3,715
+22% +$600K 0.57% 38
2022
Q4
$2.94M Sell
16,656
-1,942
-10% -$335K 0.58% 38
2022
Q3
$3.04M Buy
18,598
+2,077
+13% +$351K 0.68% 30
2022
Q2
$2.93M Sell
16,521
-10,035
-38% -$1.79M 0.67% 32
2022
Q1
$4.71M Buy
26,556
+967
+4% +$165K 0.72% 30
2021
Q4
$4.38M Buy
25,589
+122
+0.5% +$20K 0.63% 31
2021
Q3
$4.11M Buy
25,467
+676
+3% +$115K 0.68% 31
2021
Q2
$4.08M Sell
24,791
-3,093
-11% -$512K 0.69% 34
2021
Q1
$4.58M Sell
27,884
-183
-0.7% -$29.6K 0.87% 27
2020
Q4
$4.42M Buy
28,067
+1,527
+6% +$225K 0.89% 28
2020
Q3
$3.95M Buy
26,540
+590
+2% +$87.3K 0.92% 27
2020
Q2
$3.65M Buy
25,950
+9,193
+55% +$1.34M 0.95% 26
2020
Q1
$2.2M Buy
16,757
+2,195
+15% +$311K 0.67% 41
2019
Q4
$2.12M Sell
14,562
-198
-1% -$26.9K 0.44% 53
2019
Q3
$1.91M Buy
14,760
+1,388
+10% +$183K 0.41% 56
2019
Q2
$1.86M Buy
13,372
+819
+7% +$113K 0.4% 57
2019
Q1
$1.75M Buy
12,553
+729
+6% +$97.6K 0.39% 54
2018
Q4
$1.53M Buy
11,824
+799
+7% +$111K 0.4% 53
2018
Q3
$1.52M Sell
11,025
-668
-6% -$88.8K 0.45% 53
2018
Q2
$1.42M Buy
11,693
+993
+9% +$124K 0.47% 50
2018
Q1
$1.37M Buy
10,700
+1,511
+16% +$204K 0.49% 46
2017
Q4
$1.28M Sell
9,189
-2,830
-24% -$394K 0.44% 49
2017
Q3
$1.56M Buy
12,019
+38
+0.3% +$5.04K 0.53% 40
2017
Q2
$1.58M Sell
11,981
-90
-0.7% -$11.5K 0.53% 39
2017
Q1
$1.5M Buy
12,071
+2,889
+31% +$345K 0.76% 25
2016
Q4
$1.06M Buy
9,182
+8
+0.1% +$924 0.79% 26
2016
Q3
$1.08M Sell
9,174
-245
-3% -$29.7K 0.89% 21
2016
Q2
$1.14M Sell
9,419
-362
-4% -$41.1K 0.96% 20
2016
Q1
$1.06M Buy
9,781
+291
+3% +$30.1K 0.9% 21
2015
Q4
$975K Buy
+9,490
New +$954K 0.84% 21

Other funds holding JNJ

Cornerstone Advisory's JNJ Position: Q2 2026 in Review

Cornerstone Advisory increased its Johnson & Johnson (JNJ) stake by 4.1% in Q2 2026, buying an estimated $165K and bringing the position to 18,006 shares worth $4.57M. The position accounts for 0.38% of the portfolio, ranked #50.

Cornerstone Advisory first reported a position in JNJ in Q4 2015 and has held it in 43 quarters since. The position peaked at $4.71M in Q1 2022. 2,122 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cornerstone Advisory held 18,006 shares of Johnson & Johnson worth $4.57M as of Q2 2026.
  • Cornerstone Advisory bought 708 Johnson & Johnson shares in Q2 2026, an estimated $165K.
  • Johnson & Johnson made up 0.38% of Cornerstone Advisory's portfolio in Q2 2026, its #50 holding.
  • Cornerstone Advisory first reported a position in Johnson & Johnson in Q4 2015 and has held it in 43 quarters since.
  • Cornerstone Advisory's Johnson & Johnson position peaked at $4.71M in Q1 2022.
  • 2,122 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cornerstone Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.